SCHEMBL1090669

SCHEMBL1090669

c1ccc(CN2CC[C@H](Nc3nc4c(c(N5CCCCCC5)n3)CCC4)C2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.60
EHMT2 Q96KQ7 3/20 0.49
OPRK1 P41145 1/20 0.46
ROCK2 O75116 3/20 0.46
CCR2 P41597 2/20 0.46
ROCK1 Q13464 2/20 0.46
ACHE P22303 3/20 0.45
BCHE P06276 2/20 0.45
BACE1 P56817 2/20 0.45
IDH1 O75874 1/20 0.43
IDH2 P48735 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HIF1A Q16665 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MALT1 Q9UDY8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088990 1.00 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1089668 1.00 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1090769 0.98 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1089179 0.98 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1089877 0.98 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1091203 0.98 CXCR4 (0.60) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1091295 0.95 CXCR4 (0.54) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1091386 0.95 CXCR4 (0.54) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1091679 0.95 CXCR4 (0.54) CXCR4EHMT2OPRK1ROCK2CCR2
SCHEMBL1088818 0.95 CXCR4 (0.54) CXCR4EHMT2OPRK1ROCK2CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885OPRK1 61/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885OPRK1 61/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885EHMT2 2402/4885OPRK1 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.